Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica

Objective. To reduce immune-mediated damage in a rat model of neuromyelitis optica (NMO) by blocking neutrophil migration using SCH527123, a drug that inhibits CXCR2. Background. Neuromyelitis optica is a relapsing autoimmune disease that preferentially targets the optic nerves and spinal cord leadi...

Full description

Saved in:
Bibliographic Details
Main Authors: Melina V. Jones, Michael Levy
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/9034695
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850228459455905792
author Melina V. Jones
Michael Levy
author_facet Melina V. Jones
Michael Levy
author_sort Melina V. Jones
collection DOAJ
description Objective. To reduce immune-mediated damage in a rat model of neuromyelitis optica (NMO) by blocking neutrophil migration using SCH527123, a drug that inhibits CXCR2. Background. Neuromyelitis optica is a relapsing autoimmune disease that preferentially targets the optic nerves and spinal cord leading to blindness and paralysis. Part of the immunopathogenesis of this disease is thought to involve neutrophils, which are present within NMO lesions. We tested the effect of blocking neutrophil migration in an NMO rat model. Methods. The Lewis rat model of NMO uses a myelin-reactive experimental autoimmune encephalomyelitis (EAE) background with passive transfer of pooled human antibody from patients with aquaporin-4 (AQP4) seropositive NMO at onset of EAE symptoms. We treated rats early in the course of EAE with CXCR2 inhibitor and assessed the extent of neutrophil infiltration into the spinal cord and the extent of AQP4 depletion. Results. CXCR2 inhibitor decreased neutrophil migration into the spinal cord of AQP4 IgG-treated EAE rats. However, there was no difference in the acute behavioral signs of EAE or the extent and distribution of AQP4 lesions. This suggests that neutrophils are not centrally involved in the immunopathogenesis of the Lewis rat NMO disease model. Conclusions. CXCR2 inhibitor blocks neutrophil migration into the spinal cord during EAE but does not significantly reduce inflammation or AQP4 lesions in the Lewis rat model of NMO.
format Article
id doaj-art-2bb44d4f82624833971b77f41ebf2987
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-2bb44d4f82624833971b77f41ebf29872025-08-20T02:04:31ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/90346959034695Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis OpticaMelina V. Jones0Michael Levy1Department of Neurology, Johns Hopkins University, Baltimore, MD, USADepartment of Neurology, Johns Hopkins University, Baltimore, MD, USAObjective. To reduce immune-mediated damage in a rat model of neuromyelitis optica (NMO) by blocking neutrophil migration using SCH527123, a drug that inhibits CXCR2. Background. Neuromyelitis optica is a relapsing autoimmune disease that preferentially targets the optic nerves and spinal cord leading to blindness and paralysis. Part of the immunopathogenesis of this disease is thought to involve neutrophils, which are present within NMO lesions. We tested the effect of blocking neutrophil migration in an NMO rat model. Methods. The Lewis rat model of NMO uses a myelin-reactive experimental autoimmune encephalomyelitis (EAE) background with passive transfer of pooled human antibody from patients with aquaporin-4 (AQP4) seropositive NMO at onset of EAE symptoms. We treated rats early in the course of EAE with CXCR2 inhibitor and assessed the extent of neutrophil infiltration into the spinal cord and the extent of AQP4 depletion. Results. CXCR2 inhibitor decreased neutrophil migration into the spinal cord of AQP4 IgG-treated EAE rats. However, there was no difference in the acute behavioral signs of EAE or the extent and distribution of AQP4 lesions. This suggests that neutrophils are not centrally involved in the immunopathogenesis of the Lewis rat NMO disease model. Conclusions. CXCR2 inhibitor blocks neutrophil migration into the spinal cord during EAE but does not significantly reduce inflammation or AQP4 lesions in the Lewis rat model of NMO.http://dx.doi.org/10.1155/2018/9034695
spellingShingle Melina V. Jones
Michael Levy
Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
Journal of Immunology Research
title Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
title_full Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
title_fullStr Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
title_full_unstemmed Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
title_short Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis Optica
title_sort effect of cxcr2 inhibition on behavioral outcomes and pathology in rat model of neuromyelitis optica
url http://dx.doi.org/10.1155/2018/9034695
work_keys_str_mv AT melinavjones effectofcxcr2inhibitiononbehavioraloutcomesandpathologyinratmodelofneuromyelitisoptica
AT michaellevy effectofcxcr2inhibitiononbehavioraloutcomesandpathologyinratmodelofneuromyelitisoptica